Exploration of the formative mechanisms of colon-targeting composite particles of natural products prepared via mechanical dry particle coating

Autor: Chen, Zekai, Yuan, Chenyi, Hong, Weiman, Xie, Rong, Zhou, Liangliang, Li, Yangbiao, Chen, Zhenhua

Publikováno v: In Advanced Powder Technology November 2024 35(11)

Land-based transportation influences carbon emission in urbanized China: A regional spatial spillover perspective

Autor: Zeng, Chen, Chai, Bingqian, Stringer, Lindsay C., Li, Yangbiao, Wang, Zhen, Deng, Xiangzheng, Ma, Binbin, Ren, Jinming

Publikováno v: In Sustainable Cities and Society January 2024 100

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation.

Autor: Zhao W; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Jiang G; Analysis and Testing Center, Beijing Normal University, Beijing, China., Bi C; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Li Y; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Liu J; China Meitan General Hospital, Beijing, China., Ye C; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., He H; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Li L; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Song D; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Shao R; Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Publikováno v: Oncotarget [Oncotarget] 2015 Nov 10; Vol. 6 (35), pp. 37871-94.